CPT1A and cancer: Moreover, CPT1A has been shown to be highly expressed in radioresistant cancer cells and can increase the FAO rate, while inhibition of fatty acid synthesis or targeting CPT1A attenuated radioresistance and decreased radiation-mediated ERK activation [190, 191].